Date,Agency,Category,Title,Link
2. March  2026,European Medicines Agency,Guidance,"Overview of comments received ICH M4Q(R2) Guideline (Quality CTD) Consolidated stakeholder comments from industry associations, companies, and technical groups",https://www.linkedin.com/feed/update/urn:li:activity:7431603489333714944/
2. March  2026,European Medicines Agency,Guidance,European Medicines Agency Question and Answer on SPC Section 4.2 - Pharmacodynamic Properties (Veterinary Products),https://www.linkedin.com/feed/update/urn:li:activity:7431605691389472768/
2. March  2026,European Medicines Agency,Guidance,Draft Guideline on Quality Aspects of mRNA Vaccines for Veterinary Use,https://www.linkedin.com/feed/update/urn:li:activity:7431607713819897856/
2. March  2026,European Medicines Agency,Guidance,ICH Q2(R2) Validation of Analytical Procedures (Step 5) Scope & Objective,https://www.linkedin.com/feed/update/urn:li:activity:7431590127329726464/
2. March 2026,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical trials for medicines: apply for authorisation in the UK,https://www.linkedin.com/feed/update/urn:li:activity:7430503953655607297/
2. March  2026,Medicines and Healthcare products Regulatory Agency,Guidance,Get integrated scientific advice from the MHRA and NICE,https://www.linkedin.com/feed/update/urn:li:activity:7431594574407626752/
2. March  2026,Medicines and Healthcare products Regulatory Agency,Guidance,Regulating medical devices in the UK,https://www.linkedin.com/feed/update/urn:li:activity:7431596848416542720/
2. March  2026,Medicines and Healthcare products Regulatory Agency,Guidance,Register medical devices to place on the market,https://www.linkedin.com/feed/update/urn:li:activity:7431599470565502976/
2. March  2026,Medicines and Healthcare products Regulatory Agency,Guidance,Regulation of medical devices in Northern Ireland,https://www.linkedin.com/feed/update/urn:li:activity:7431601439908732928/
2. March  2026,Ministry of Health New Zealand,Guidance,Policy Statement - Declaring excipient(s) with known effect in data sheets,https://www.linkedin.com/feed/update/urn:li:activity:7431585612966785024/
2. March  2026,Ministry of Health New Zealand,Guidance,Verification Pathway for New Medicine Applications - Draft for Consultation (February 2026),https://www.linkedin.com/feed/update/urn:li:activity:7431587846739705856/
2. March 2026,Swissmedic,Forms,Swissmedic Forms for March 2026,
2. March 2026,Swissmedic,Guidance,Performance Studies of IVD,https://www.linkedin.com/feed/update/urn:li:activity:7430501332953956352/
2. March  2026,Swissmedic,Guidance,swissdamed Machine-to-Machine REST API Documentation,https://www.linkedin.com/feed/update/urn:li:activity:7431580451112280064/
2. March  2026,Swissmedic,Report,Authorisation of complementary and herbal medicinal products 2025 Market Overview (2025):,https://www.linkedin.com/feed/update/urn:li:activity:7431582802162167808/
2. March 2026,Therapeutic Goods Administration,Guidance,Complying with the Unique Device Identification requirements for medical devices Guidance for sponsors and manufacturers on complying with Australian UDI requirements,https://www.linkedin.com/feed/update/urn:li:activity:7430506125483175936/
2. March 2026,Therapeutic Goods Administration,Guidance,Manufacturing and supplying surgical loan kits to Australian hospitals,https://www.linkedin.com/feed/update/urn:li:activity:7430508008637468672/




